Vitrafy Life Sciences Limited

ASX:VFY Stock Report

Market Cap: AU$108.5m

Vitrafy Life Sciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Kate Munnings

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.5%
Management average tenureno data
Board average tenure2.1yrs

Recent management updates

Recent updates

CEO

Kate Munnings (57 yo)

less than a year

Tenure

Ms. Kathryn Marian Munnings, also known as Kate, serves as Chief Executive Officer & Managing Director of Vitrafy Life Sciences Ltd and serves as its Director since October 10, 2024. She is Independent Non...

Board Members

NamePositionTenureCompensationOwnership
Brenton Michael Owens
Co-Founder6.8yrsAU$353.49k3%
A$ 3.3m
Kathryn Munnings
CEO, MD & Directorless than a yearno data0.46%
A$ 501.5k
Vaughan Webber
Independent Non-Executive Director2.1yrsAU$65.00k0.31%
A$ 332.8k
Sonia Petering
Independent Non-Executive Chair1.8yrsAU$211.00k0.27%
A$ 294.1k
John McBain
Chair of Scientific Advisory Board & Independent Non-Executive Director4.3yrsAU$60.00k3.01%
A$ 3.3m
Anand Srinivasan
Member of Scientific Advisory Boardno datano datano data
Debra Gook
Member of Scientific Advisory Boardno datano datano data
Denese Marks
Member of Scientific Advisory Boardno datano datano data

2.1yrs

Average Tenure

Experienced Board: VFY's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 02:49
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vitrafy Life Sciences Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martyn JacobsBell Potter